Company News 

Smith & Nephew a hunter not a target

Smith & Nephew a hunter not a target

Are you a buyer or a takeover target? That is the question medical device makers are having to ask of themselves following a period of intense consolidation. Deals such as Johnson and Johnson’s $21.3bn (£16.2bn) acquisition of orthopaedic company Synthes in 2012, or the $14bn merger that created Zimmer Biomet in 2014, have put pressure on companies to increase their scale and efficiency. Those unable to expand are likely to get left behind.

To continue reading, subscribe today

and enjoy unlimited access to the following:

  • Tips of the Week
  • Funds coverage
  • Weekly features on big investment themes
  • Trading ideas
  • Comprehensive companies coverage
  • Economic analysis
Subscribe
Subscribe to Investors Chronicle

Related topics

Subscribe today

Full access for just £3.37 a week:

• Tips and recommendations - to beat the market 
• Portfolio clinic & Mr Bearbull - build a well-planned portfolio 
• Expert tools - track and manage investments effortlessly
• Plus free delivery to your home or office

Subscribe Now